Concepedia

Publication | Closed Access

Dolutegravir Monotherapy Versus Dolutegravir/Abacavir/Lamivudine for Virologically Suppressed People Living With Chronic Human Immunodeficiency Virus Infection: The Randomized Noninferiority MONotherapy of TiviCAY Trial

57

Citations

24

References

2018

Year

Abstract

NCT02596334 and EudraCT 2015-002853-36.

References

YearCitations

Page 1